Showing results (441-450 of 457) with videos related to

Sort By:
Pageof 46
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersAnna-Katharine Brem, Zunera Khan, Ellie Pickering, et al.
Frontiers in Public Health|October 7, 2022
Parallel randomized controlled feasibility trials of the "Active Brains" digital intervention to protect cognitive health in adults aged 60-85Rosie Essery, Sebastien Pollet, Katherine Bradbury, et al.
Plos One|June 30, 2017
Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendationsLucy Webster, Derek Groskreutz, Anna Grinbergs-Saull, et al.
Trials|April 5, 2019
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Trials|July 21, 2020
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Neurology|April 4, 2020
Research criteria for the diagnosis of prodromal dementia with Lewy bodiesIan G McKeith, Tanis J Ferman, Alan J Thomas, et al.
The Journal of Prevention of Alzheimer'S Disease|January 22, 2026
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's diseaseClaude M Wischik, Richard Stefanacci, Peter Bentham, et al.
Alzheimer'S & Dementia (New York, N. Y.)|May 24, 2024
Genetic associations with psychosis and affective disturbance in Alzheimer's diseaseInga Margret Antonsdottir, Byron Creese, Lambertus Klei, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 9, 2013
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the futureYonas E Geda, Lon S Schneider, Laura N Gitlin, et al.
Health Technology Assessment (Winchester, England)|June 20, 2017
Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendationsLucy Webster, Derek Groskreutz, Anna Grinbergs-Saull, et al.
Pageof 46